(Reuters) – Activist investor Carl Icahn and U.S. life sciences firm Illumina failed to reach a settlement during weeks-long private negotiations before he began a proxy fight earlier this month, a regulatory filing showed on Thursday.
Latest posts by Crypto Editor (see all)
- FP Markets Webinar for January 31: Explore TradingView with FP Markets Market Analyst Aaron Hill - January 18, 2024
- Crude Oil Price Forecast – Crude Oil Continues to Bounce Around - January 18, 2024
- AUD/USD Forecast – Australian Dollar Continues to Test Support - January 18, 2024